Listed Romanian healthcare group Medlife is looking to neighbouring countries for expansion, says its CEO. We analyse the opportunity in the four that he singled out, each of which is ripe for consolidation.
HBI talks to Dr Helmut Schuehsler, chairman and CEO at TVM Capital Healthcare Partners, Dubai and Singapore, about the group’s prospective exit from its current healthcare assets, its hunt for new investments, and the MENA market more specifically.
According to a report by real-estate investor Octopus Healthcare, both current and new investors in UK elderly care will be allocating increasing resources to the sector, despite the market experiencing significant financial challenges. We speak to the company's CEO, Benjamin Davis, about why UK elderly care remains a hotspot for investment.
International dialysis provider Diaverum has expanded in Brazil with the acquisition of three clinics following its initial entry into Latin America's largest market in January, 2018.
Soon-to-sell global dialysis service provider Diaverum has bought Macedonia's largest operator, with the CEO adding it could be a platform for further expansion in the region. We talk to Diaverum, dig further into the Macedonian dialysis market and disclose the revenue of the acquired company.
Swedish-telehealth company KRY has begun its UK roll-out. At the same time, competitor Doctrin exclusively tells Healthcare Europa that it too is in discussions with NHS health authorities and is preparing to expand. UK-based Babylon soon could be facing its first serious competitor for home market share. Healthcare Europa assesses the UK market and these competing business models.
Asia-Pacific integrated healthcare platform Fullerton Health has completed an investment in a Shanghai hospital through its Sino-based subsidiary, Fullerton Health China.
Recent developments point to pan-Asian hospital group IHH scaling down Acibadem, its Turkey-based subsidiary. What does this mean for its interest in Europe? We talk to well-placed sources about what a falling lira, shareholder restructuring, asset sales in Bulgaria and Macedonia, and IHH’s acquisition of Indian chain Fortis might mean.
Recent developments point to pan-Asian hospital group IHH scaling down Acibadem, its Turkey-based subsidiary. What does this mean for its interest in Europe? We talk to well-placed sources about what a falling lira, shareholder restructuring, asset sales in Bulgaria and Macedonia, and IHH's acquisition of Indian chain Fortis might mean.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
